{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:18:18Z","timestamp":1787242698448,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The association between various biomarkers and the risk of lupus nephritis (LN) has been extensively investigated. However, a dearth of readily available, specific, and sensitive diagnostic biomarkers for LN remains. This study aimed to examine the levels of Afamin in the urine and plasma of patients with systemic lupus erythematosus (SLE) and to evaluate its potential utility for diagnosing LN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study enrolled 31 LN\u2013SLE patients, 31 non-LN\u2013SLE patients, and 27 healthy controls (HC). First, tandem mass tag (TMT)\u2013based proteomic screening of urine and plasma (\n                      <jats:italic>n<\/jats:italic>\n                      = 15 per group) identified Afamin as a significantly upregulated protein in LN. Subsequently, ELISA validation confirmed that both uAfamin and pAfamin levels were markedly higher in the LN group. The diagnostic performance of uAfamin for active LN was further evaluated using receiver operating characteristic (ROC) curve analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Levels of both urinary and plasma Afamin were significantly elevated in patients with LN\u2013SLE compared to those with non-LN\u2013SLE. Moreover, uAfamin and pAfamin levels demonstrated robust correlations with multiple clinical indicators of disease activity, including 24h urinary total protein (24hUTP), creatinine, urea, hematuria, pyuria, SLEDAI, and renal SLEDAI. Multivariable linear regression analysis established uAfamin as an independent determinant of renal SLEDAI scores. Consistent with this, ROC curve analysis confirmed that uAfamin possesses a strong capacity to diagnose LN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The uAfamin level serves as a biomarker for LN, aiding in monitoring disease progression and suggesting a new avenue for personalized treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1696288","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:29:59Z","timestamp":1764311399000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Urine Afamin as a biomarker of lupus nephritis"],"prefix":"10.3389","volume":"16","author":[{"given":"Shiyu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"B1","unstructured":"Systemic lupus erythematosus\n          \n          \n            \n              Justiz Vaillant\n              AA\n            \n            \n              Goyal\n              A\n            \n            \n              Varacallo\n              MA\n            \n          \n          Treasure Island (FL\n          StatPearls Publishing\n          StatPearls\n          \n          2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"849684","DOI":"10.1155\/2012\/849684","article-title":"Lupus nephritis: an overview of recent findings","volume":"2012","author":"de Zubiria Salgado","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70262-9","article-title":"Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group","volume":"35","author":"Korbet","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"B4","article-title":"The benefit of early treatment with immunosuppressive agents in lupus nephritis","volume":"21","author":"Esdaile","year":"1994","journal-title":"J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.20345","article-title":"Biomarkers in systemic lupus erythematosus: II. Markers of disease activity","volume":"50","author":"Illei","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar2816","article-title":"Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study","volume":"11","author":"Schwartz","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.berh.2024.101938","article-title":"Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease","volume":"37","author":"Piga","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"638413","DOI":"10.1155\/2010\/638413","article-title":"Biomarkers for lupus nephritis: a critical appraisal","volume":"2010","author":"Mok","year":"2010","journal-title":"J BioMed Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.5.435","article-title":"Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment","volume":"62","author":"Fiehn","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.9.1620","article-title":"High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients","volume":"10","author":"Austin","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.3390\/ijms22137143","article-title":"Immune-related urine biomarkers for the diagnosis of lupus nephritis","volume":"22","author":"Morell","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12014-018-9183-3","article-title":"Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis","volume":"15","author":"Pang","year":"2018","journal-title":"Clin Proteomics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2056","article-title":"Proteomic identification of urinary biomarkers of diabetic nephropathy","volume":"30","author":"Rao","year":"2007","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1477-5956-12-42","article-title":"Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model","volume":"12","author":"Zhao","year":"2014","journal-title":"Proteome Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080830","article-title":"Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography","volume":"8","author":"Kalantari","year":"2013","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.2345","article-title":"Complement components, proteolysis\u2212related, and cell communication\u2212related proteins detected in urine proteomics are associated with IgA nephropathy","volume":"124","author":"Mucha","year":"2014","journal-title":"Pol Arch Med Wewn"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.08.016","article-title":"Label-free mass spectrometric profiling of urinary proteins and metabolites from paediatric idiopathic nephrotic syndrome","volume":"452","author":"Sedic","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0126","article-title":"Urine afamin and afamin\u2013creatinine ratio as biomarkers for kidney injury","volume":"12","author":"Pang","year":"2018","journal-title":"biomark Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/diagnostics10070483","article-title":"Cardiovascular risk and statin therapy considerations in women","volume":"10","author":"Gheorghe","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheumatic Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"B23","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"359647","DOI":"10.1155\/2012\/359647","article-title":"Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases","volume":"2012","author":"Xuejing","year":"2012","journal-title":"J BioMed Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-022-03112-9","article-title":"Prognostic value of modified National Institute of Health activity and chronicity scoring in determining complete renal response in newly diagnosed lupus nephritis: a retrospective single centre study","volume":"54","author":"Singh","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/biom11070928","article-title":"Clinical and immunological biomarkers for systemic lupus erythematosus","volume":"11","author":"Yu","year":"2021","journal-title":"Biomolecules"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-004-0013-4","article-title":"Biomarkers in systemic lupus erythematosus","volume":"6","author":"Illei","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/096120330000900105","article-title":"Usefulness of detection of complement activation products in evaluating SLE activity","volume":"9","author":"Nagy","year":"2000","journal-title":"Lupus"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1398.032","article-title":"Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis","volume":"1109","author":"Schwartz","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1053\/j.ajkd.2024.11.004","article-title":"Association of serum afamin concentrations with kidney failure in patients with CKD: findings from the german CKD cohort study","volume":"85","author":"Kollerits","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107435","DOI":"10.1016\/j.ympev.2022.107435","article-title":"Evolution of the albumin protein family in reptiles","volume":"169","author":"Broussard","year":"2022","journal-title":"Mol Phylogenet Evol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"103979","DOI":"10.1016\/j.jprot.2020.103979","article-title":"Use of liquid chromatography-tandem mass spectrometry to perform urinary proteomic analysis of children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis","volume":"230","author":"Fang","year":"2021","journal-title":"J Proteomics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.3390\/diagnostics13193158","article-title":"Clinical significance of adropin and afamin in evaluating renal function and cardiovascular health in the presence of CKD-MBD biomarkers in chronic kidney disease","volume":"13","author":"Kaur","year":"2023","journal-title":"Diagnostics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0961203307085879","article-title":"Review: vitamin D, immunity and lupus","volume":"17","author":"Cutolo","year":"2008","journal-title":"Lupus"},{"key":"B35","article-title":"Vitamin D in lupus - new kid on the block","volume":"68","author":"Kamen","year":"2010","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10405","article-title":"Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory","volume":"5","author":"Bishop","year":"2021","journal-title":"JBMR Plus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/biom13040709","article-title":"Vitamin D and autoimmune rheumatic diseases","volume":"13","author":"Athanassiou","year":"2023","journal-title":"Biomolecules"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211004727","article-title":"Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis","volume":"30","author":"Yu","year":"2021","journal-title":"Lupus"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041439","article-title":"Potential drug targets for systemic lupus erythematosus identified through Mendelian randomization analysis","volume":"104","author":"Fan","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"108505","DOI":"10.1016\/j.isci.2023.108505","article-title":"ICAM-1 mediated cell-cell adhesion exerts dual roles on human B cell differentiation and IgG production","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1696288\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:30:01Z","timestamp":1764311401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1696288\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2025.1696288"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1696288","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"1696288"}}